Aripiprazole Tablets — Class II drug recall D-0645-2025
Ongoing recall by Ascend Laboratories, LLC, reported 2025-09-24, distributed nationwide. Superpotent drug
| Recall number | D-0645-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Ascend Laboratories, LLC, Bedminster, NJ, United States |
| Recall initiated | 2025-08-28 |
| Classified | 2025-09-12 |
| Reported by FDA | 2025-09-24 |
| Distributed | Nationwide (US) |
| Quantity | 2,256 bottles |
| Reason classes | potency |
| NDC | 67877-0430, 67877-0430-01, 67877-0430-03, 67877-0430-05, 67877-0430-32, 67877-0430-33, 67877-0430-38, 67877-0431, 67877-0431-01, 67877-0431-03, 67877-0431-05, 67877-0431-32, 67877-0431-33, 67877-0431-38, 67877-0432, 67877-0432-01, 67877-0432-03, 67877-0432-05, 67877-0432-32, 67877-0432-33, 67877-0432-38, 67877-0433, 67877-0433-01, 67877-0433-03, 67877-0433-05 and 15 more |
| Lot numbers | 24144162 |
| Expiration dates | 2027-09 |
Product
Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-432-03
Reason for recall
Superpotent drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0645-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.